National Analyses on Survival in Maltese Adult Patients on Renal Replacement Therapy Started During 2009

National Analyses on Survival in Maltese Adult Patients on Renal Replacement Therapy Started During 2009–2012

Published:2019-12-12 Issue: Volume: Page:117-123
ISSN:2397-6764
Container-title:European Medical Journal
language:
Short-container-title:EMJ

Author:

Baldacchino Ian¹,Debattista Sarah²,Debattista Daniel²,Balzan Gabriella³,Abdilla Stefania¹,Baldacchino Lisa³,Borg Gabriel¹,Buttigieg Sacha¹,Calleja Stafrace Nadine¹,Cutajar Karl¹,Galea Marica¹,Sciberras Whitney¹,Xerri Thelma²,Camilleri Liberato⁴,Farrugia Emanuel²

Affiliation:

1. Department of Primary Healthcare, Floriana, Malta

2. Mater Dei Hospital, Msida, Malta

3. Karin Grech Rehabilitation Hospital, Pieta, Malta

4. Full time Associate Professor, University of Malta, Msida, Malta

Abstract

Chronic kidney disease patients on maintenance dialysis (CKD 5D) experience major morbidity and mortality. No data on survival in Maltese dialysis patients exist; therefore, the aim of this study was to rigorously examine survival statistics in a complete cohort of Maltese CKD 5D patients. The study population was comprised of all incident chronic patients (N=328) starting dialysis at the renal unit, Mater Dei hospital, Msida, Malta, for 4 consecutive years (2009–2012). Each yearly cohort was analysed in detail up to 31st December 2017, providing up to 8 years follow-up. Demographics (male 65%; female 35%), aetiology of renal failure (diabetic kidney disease: n=191; 58.2%), comorbidities, transplant status, and death were documented. Data collection and follow up were completed and statistical analysis was performed on the aggregated cohorts with SPSS version 23 with censoring up to 31st December 2017. The cumulative adjusted 5-year overall survival in Maltese CKD 5D patients was 0.36 and 0.25 at 8 years. No statistical difference was observed according to the year of starting dialysis. Cox regression analysis showed that age and transplant status influenced survival. The unadjusted hazard of death increased by 3% for every 1-year increase in age and was increased by 7% if the patient did not receive a transplant, and overall 22% (n=72) of the entire cohort eventually received transplants. This study reports an approximate 65% mortality at 5 years in Maltese haemodialysis patients, a poor prognosis that, despite optimal medical management, is consistent with worldwide reports.

Publisher

European Medical Group

Subject

General Medicine

Reference13 articles.

1. Pippias M et al. Renal replacement therapy in Europe: A summary of the 2012 ERA-EDTA registry annual report. Clin Kidney J. 2015;8(3):248-61.

2. National Statistics Office (NSO) Malta. Population statistics (revisions): 2012-2016. Available at: https://nso.gov.mt/en/News_Releases/View_by_Unit/Unit_C5/Population_and_Migration_Statistics/Documents/2018/News2018_022.pdf. Last accessed: 30 August 2018.

3. Wolfe RA et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-30.

4. Spithoven EM et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: Prevalence and survival-an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant. 2014;29(Suppl 4):iv15-25.

5. Navaneethan S et al. Mortality outcomes of patients with chronic kidney disease and chronic obstructive pulmonary disease. Am J Nephrol. 2016;43(1):39-46.